Provided by Tiger Trade Technology Pte. Ltd.

Dare Bioscience

0.7166
+0.00360.50%
Volume:175.32K
Turnover:125.21K
Market Cap:14.09M
PE:-0.92
High:0.7299
Open:0.7290
Low:0.6910
Close:0.7130
52wk High:3.78
52wk Low:0.6900
Shares:19.67M
Float Shares:17.33M
Volume Ratio:0.49
T/O Rate:1.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7779
EPS(LYR):-1.1986
ROE:-2543.13%
ROA:-39.29%
PB:-25.13
PE(LYR):-0.60

Loading ...

Daré Bioscience Wins NIH Award of About $908,000 for Preterm Birth Program DARE-PTB2

Reuters
·
Aug 31

Press Release: KB HOME NAMES CASEY DARE as President of ITS TAMPA Division

Dow Jones
·
Aug 28

Press Release: Daré Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor "Why Now" On-Demand Series

Dow Jones
·
Aug 27

Dare Bioscience - Files for Resale of up to 8,934,345 Shares of Common Stock - SEC Filing

THOMSON REUTERS
·
Aug 27

Daré Bioscience Posts Phase 1 Data Showing Topical Sildenafil Cream Well Tolerated in Postmenopausal Women

Reuters
·
Aug 26

Daré Bio CEO Flags Ovaprene Interim Phase 3 Results as Potential Catalyst in Investor Interview

Reuters
·
Aug 25

Press Release: Daré Bioscience CEO Outlines Commercial Transformation, Pipeline Momentum and Potential Key Catalysts in Virtual Investor CEO Connect Segment

Dow Jones
·
Aug 25

Daré Bioscience DARE-HPV Program Advances with Non-Dilutive US Government Funding

Reuters
·
Aug 18

DarÉ Bioscience CEO Sabrina Martucci Johnson Named to Forbes 2026 “50 over 50: Innovation” List

THOMSON REUTERS
·
Aug 18

DARÉ Bioscience CEO Sabrina Martucci Johnson Named to Forbes 2026 “50 Over 50: Innovation” List

GlobeNewswire
·
Aug 18

Daré Bioscience Prices USD 6 Million Registered Direct Offering at USD 1.37 Per Share

Reuters
·
Aug 17

Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE) and Daré Bioscience (DARE)

TIPRANKS
·
Aug 16

Dare Bioscience Prices $6 Million Registered Direct Offering; Shares Fall

MT Newswires Live
·
Aug 15

Daré Bioscience to Issue Series A, Series B Warrants in Private Placement for up to 8,759,162 Shares

Reuters
·
Aug 15

NASDAQ Trade Halt Volatility Trading Pause at 12:45 Pm

Reuters
·
Aug 15

DarÉ Bioscience Announces Pricing of $6.0 Million Registered Direct Offering Priced At-the-Market Under NASDAQ Rules

THOMSON REUTERS
·
Aug 15

Daré Bioscience Announces Pricing of $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswire
·
Aug 15

VistaGen Q1 Revenue Rises on Licensing Agreement Expiration

Reuters
·
Aug 14

Dare Bioscience Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Dare Bioscience, Inc. Q2 EPS USD -0.2

THOMSON REUTERS
·
Aug 14